Opsis Therapeutics is a biotechnology company developing stem cell treatments for treating retinal diseases.
Opsis Therapeutics is a biotechnology company developing stem cell treatments for treating retinal diseases.
Opsis Therapeutics is a biotechnology company developing stem cell treatments for treating retinal diseases that is headquartered in Madison, Wisconsin and was founded in 2016 by David Gamm and Carter Cliff.
Opsis Therapeutics is a biotechnology company developing stem cell treatments for treating retinal diseases.